Skip to content

APOTHEEK DE BAUW

Active Private limited companyfounded 1997active for 29 yearsBrusselsesteenweg 119, 1730 AsseKBO/BCE: BE 0461.340.611 subsidiary of

Lifetime

20 annual accounts with figures on one time axis, 28 filings since 1998
peak of €543,951 in 2025
€543,951▲ 26.3%
lowest -€133,893 in 2023
€150,008▲ 208%
peak of €715,238 in 2017
€677,920▲ 17.3%
€1.4m▼ 8.5%
peak of 5.2 FTE in 2018
4.2 FTE▼ 12.5%
Board3 names since 2020
1 director
Owners
  
Documentsfilings and deeds
29-06-202632 days before the deadline
2025abbreviated format
Gross margin from €430,532 to €543,951Result from €48,701 to €150,008Staff from 4.8 FTE to 4.2 FTEEquity from €577,913 to €677,920

Key points

from the 2025 annual accounts

Result

€150,008 ▲ 208%
€48,7002024€150,0002025

The result rose in 2025 from €48,701 to €150,008.

Staff

4 employees on 31-12-2025
012021212022102024022025

In 2025, nobody joined and 2 employees left.

Filings

28 annual accounts since 1998
AprilJune31 JulyOctober200020102020

Two of the last ten came late. The 2023 accounts came in latest, 20 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,389 companies had the same profile as APOTHEEK DE BAUW has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,389 companies, not a prediction for APOTHEEK DE BAUW. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Auditor,
  • 100%equity €506,560 (2025) · annual accounts 2025 of
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0461340611
Company renamed from VAN VAERENBERGH to APOTHEEK DE BAUW Registered office moved within Asse · The registered office moved from Brusselsesteenweg 123, 1730 Asse to Brusselsesteenweg 119 bus 1, 1730 Asse · Registered office clause: Brusselsesteenweg 119 bus 1, 1730 Asse · General meeting of 31-01-2024 · Gazette deed
1 director appointed, 1 resignation resigns · appointed · acts as permanent representative · General meeting of 31-12-2020 · Gazette deed
Demerger: VAN VAERENBERGH splits off to BVV Capital decrease of €1,651.94 to €16,940.07 · The capital fell from €18,592.01 to €16,940.07 · (revisoraal verslag splitsing en inbreng in natura) and (sole director) appointed · General meeting of 27-11-2020 · Gazette deed
All 45 events

Comparable companies

same main activity, similar in size and age
Company
APOTHEEK DE BAUW Asse €2.1m €543,951 32.4% 4.2
PHARMACIE VOSS-RICHARD Verlaine €2.4m €542,335 26.2% 4.4
APOTHEEK MAHIEU Waregem €2.3m €622,727 73.9% 4.1
LA BOVERIE Namur €1.9m €583,801 22.9% 4.1
PHARMALORRAINE Aubange €2.3m €465,884 71.9% 3.8
PHARMACIE DU BON AIR Anderlecht €1.8m €461,013 34.1% 4.4
APOTHEEK NOTEBAERT Beernem €2.0m €421,954 -2.6% 4.6

These companies have the same main activity as APOTHEEK DE BAUW: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.8m and €2.4m, founded between 1995 and 2002.

Official details

Source: KBO
Status
Active since 27-08-1997Normal situation
Activity
Retail sale of pharmaceutical productsNACE 47730
Joint committee
313Pharmacies and pricing offices · annual accounts 2025
Establishment unit
2.083.266.1291730 Asse, since 10-09-1997
Financial year end
31 December
Peppol
Reachable since 08-07-2025
Company details

Annual accounts 2025

≈ €1.9mestimated
€2.1m▼ 1.5%
Employeeson 31-12-2025
4▼ 33.3%
Filing
Filed on 29-06-2026, 32 days before the end of the filing period
Financials

Insights on APOTHEEK DE BAUW

APOTHEEK DE BAUW files the abbreviated format. That format states no turnover. The gross margin rose from €233,396 in 2006 to €543,951 in 2025.

The balance sheet grew most from 2021 to 2023 through fixed assets.

holds all the shares.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about APOTHEEK DE BAUW

What is the company number of APOTHEEK DE BAUW?
The company number of APOTHEEK DE BAUW is 0461.340.611. The VAT number is the same number with BE in front: BE 0461.340.611.
Where is APOTHEEK DE BAUW based?
The registered office is at Brusselsesteenweg 119, 1730 Asse.Company details
What does APOTHEEK DE BAUW do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of APOTHEEK DE BAUW?
APOTHEEK DE BAUW is a private limited company (BV).
When was APOTHEEK DE BAUW founded?
APOTHEEK DE BAUW was founded on 27-08-1997.
Is APOTHEEK DE BAUW still active?
Yes, APOTHEEK DE BAUW is an active enterprise in the KBO register.
How many employees does APOTHEEK DE BAUW have?
APOTHEEK DE BAUW had an average of 4.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does APOTHEEK DE BAUW fall under?
In its 2025 annual accounts, APOTHEEK DE BAUW states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of APOTHEEK DE BAUW?
The turnover in financial year 2025 is ≈ €1.9m. This figure is estimated from the gross margin of €543,951 and 42 comparable companies (NACE 477). It probably lies between €1.5m and €2.6m.
Is APOTHEEK DE BAUW profitable?
In financial year 2025, APOTHEEK DE BAUW made a profit of €150,008.
Where can I find the annual accounts of APOTHEEK DE BAUW?
APOTHEEK DE BAUW filed 28 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of APOTHEEK DE BAUW due?
APOTHEEK DE BAUW must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.